KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 7,110.00
+80.00 (1.14%)
At close: Jul 31, 2026
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 77.55 billion as of July 31, 2026. Its market cap has decreased by -51.83% in one year.
Market Cap
77.55B
Enterprise Value
87.87B
Revenue
91.42B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,110.00
ChartMarket Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 77.55B, a decrease of -57.80%. That is a compound annual growth rate of -13.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 77.55B | -45.31% |
| Dec 30, 2025 | 141.79B | -15.09% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HYUNDAI BIOLAND | 96.90B |
| OPTUS Pharmaceutical | 96.35B |
| H.PIO | 87.82B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 85.27B |
| Daehan Nupharm | 78.60B |
| Sam-A Pharm. | 74.52B |
| Hwail Pharmaceutical | 73.57B |
| Polaris AI Pharma | 68.41B |